14 June 2024 – Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces the successful completion of its SOC 2®(System and Organization Controls 2) Type 1 audit, achieving compliance with the leading industry standards for customer data security. 

 

Developed by the American Institute of Certified Public Accountants (AICPA), a SOC 2 information security standard is a report that validates controls relevant to security, availability, integrity, confidentiality, and privacy.

 

Cresset is committed to providing mission-critical data to industries such as pharmaceutical, biotechnology, and agrochemical. Data integrity and security is a fundamental part of how Cresset manages user identity. SOC2 Type 1 compliance represents a commitment that secure systems and controls are maintained by the organization on an ongoing basis.

 

Commenting on the accreditation, Cresset’s Head of IT Iain Ronayne said: “Achieving SOC 2 Type 1 compliance is a powerful endorsement of the strength, resilience, and effectiveness of our IT infrastructure and security processes, which have been thoroughly audited and validated by independent experts."

 

Cresset were aided in achieving SOC 2 compliance by Kontain, a security advisory organization whose expertise in information security guided them through the process, from assessment to implementation of security controls. 

     

This support ensured Cresset fully met the SOC 2 requirements and strengthened their overall security. The successful achievement of SOC 2 Type 1 compliance demonstrates Cresset's commitment to protecting customer data and Kontain's ability to help organizations reach their security goals.

 

The audit was completed with the help of Johanson Group LLP, a premier certification body helping organizations to obtain and maintain global compliance standards. SOC 2 has a rigorous requirement on how companies handle customer data and information, so compliance guarantees there are established and implemented organizational practices in place to safeguard customer data.

 

Cresset’s Chief Technology Officer Dr Tim Cheeseright commented: “I’m delighted that we have passed our SOC 2 Type 1 audit. This is an important milestone for Cresset, and further demonstrates our commitment to providing our customers with the highest standards of data security and privacy.”

 

For more information visit https://www.cresset-group.com/about/commitment-cybersecurity/ or email compliance@cresset-group.com

 

Chemists in the world’s leading research organizations use Cresset solutions to discover, design, optimize, synthesize and track the best small molecules. Our patented CADD Software, collaborative Torx® DMTA design-make-test-analyze platform, and expert Discovery CRO scientists, enable chemists to enhance efficiency and win the race to scientific success in industry sectors including pharmaceuticals, agrochemicals, fine chemicals and flavors and fragrances.    

 

Charlotte Winspear

PR & Social Executive

ramarketing